Q-TOF Mass Spectrometry Market

Q-TOF Mass Spectrometry Market Outlook (2023 to 2033)

According to this latest study by Fact.MR, the global Q-TOF mass spectrometry market stands at US$ 832 million in 2023 and is forecasted to expand at 6.9% CAGR over the decade to reach US$ 1.63 billion by the end of 2033.

The section of mass spectrometry known as Q-TOF mass spectrometry uses the time of flight measurements to determine the particle's mass-to-charge proportion and is one of several other mass spectrometry techniques available in the global industry landscape.

In Quadrupole-Time of Flight (Q-TOF) mass spectrometry, an electric field of undetermined strength is used to accelerate the particles. The effects of other particles changing the particle with equal kinetic energy are accelerated as a result. In mass spectrometry experiments, a collision cell is situated between a quadrupole and a TOF analyzer to cause fragmentation.

• Q-TOF mass spectrometry accounts for around 10% share of the global spectrometry market in 2023.

Sales of Q-TOF mass spectrometry systems are anticipated to rise as a result of factors such as the widening scope of Q-TOF mass spectrometry applications in pharmaceutical and biotechnology firms and the expansion of research and development initiatives in the industry. Supportive programs by government organizations and a growing emphasis on mass spectrometry research are projected to be the primary drivers of the Q-TOF mass spectrometry market expansion going forward.

Rapid innovation in Q-TOF technologies is also projected to revolutionize the future of mass spectrometry workflow in the long run. The development of the handheld and portable devices needed for Q-TOF mass spectrometry operations is forecasted to open up new frontiers of opportunities for new as well as established Q-TOF mass spectrometry companies. These devices have enhanced imaging capabilities for use during sample analysis. It lessens the work required to transfer large, hefty samples to labs for chemical examination.

• In June 2022, Waters Corporation, a leading provider of analytical lab instruments, announced the launch of its new instruments. The line-up included a Xevo™ G3 quadrupole time-of-flight (QTof) mass spectrometer, which is a high-performance benchtop mass spectrometer.

Report Attributes	Details
Q-TOF Mass Spectrometry Market Size (2023)	US$ 832 Million
Projected Market Value (2033F)	US$ 1.63 Billion
Global Market Growth Rate (2023 to 2033)	6.9% CAGR
Biotechnology Application Share (2023)	40%
Key Companies Profiled	Waters Corporation Agilent Technologies Inc. Bruker Corporation SCIEX Shimadzu Corporation Danaher Thermo Fisher Scientific Inc. Shimadzu PerkinElmer Inc.

How Can Start-ups Penetrate the Q-TOF Mass Spectrometry Space?

“Product Innovation and Capital Raise Essential for New Q-TOF MS Companies”

Many new companies in the spectrometry industry are concentrating on the development of novel methods and devices. Emerging mass spectrometry instrument manufacturers are actively funding R&D initiatives that enable them to develop unique products, which helps further with maximizing market revenue.

• Andson Biotech, a Georgia-based start-up, creates brand-new sensors in pursuit of the most innovative new cell and gene therapies. With mass spectrometry, Andson's sensors make it possible to measure significant biomolecules quickly and precisely to guarantee the quality of drug products. It enables mass spectrometry to fulfill the role of a true process analytical technology.
• In August 2020, MOBILion Systems, a leading provider of analytical instruments for biotech and healthcare applications, announced that it had raised US$ 35 million in a new venture capital funding round. The company intended to use the raised financing to build its commercial team ahead of its first product launch.

Through this elaborate Q-TOF mass spectrometry research by skilled analysts at Fact.MR, a market research and competitive intelligence provider, start-ups can know more about trends such as local supply, pricing trends, product standards, safety regulations, and new developments that could alter the current or future competitive landscape.

How is Market Growth Being Hampered to Some Extent?

“Availability of Substitutes and Dearth of Qualified Professionals in Some Regions”

Market growth is expected to be hindered over the coming years by the rising use of some analysis techniques as Q-TOF mass spectroscopy substitutes. Market expansion is anticipated to be hampered by high costs related to research and development, a lack of adequate infrastructure, and rising system prices as a result of technological advancements.

Along with these factors, the market is expected to face challenges from a lack of favorable reimbursement scenarios and technology penetration in developing economies, high capital expenditures for the establishment of production facilities, and inadequate infrastructure in low- and middle-income countries.

The capital expenditure required to install and maintain these devices is anticipated to impede the expansion of the global market. Small diagnostic clinics and laboratories cannot typically afford Q-TOF mass spectrometers, especially in developing nations. Q-TOF mass spectrometry requires qualified personnel to run the equipment. Additionally, high product prices and a shortage of qualified professionals to operate these devices are hampering the sales of Q-TOF mass spectrometry machines.

Country-wise Insights

Why are Q-TOF Mass Spectrometry Providers Targeting the United States?

“Rising Demand for High Resolution and Precise Q-TOF Mass Spectrometers in Research Institutes”

Rising number of research institutions, more spending on R&D activities, a favorable funding environment, a solid foundation of healthcare facilities, and an increase in the number of procedures involved in drug development are the factors driving market expansion in the United States.

The market is expanding as a result of increasing Q-TOF mass spectrometry instruments usage in the food and beverage industry, rising demand for high-resolution and precise Q-TOF mass spectrometers in research institutes, and increased R&D in the biotechnology sector.

What is Supporting the Sales Growth of Q-TOF Mass Spectrometers in China?

“Rising Mass Spectrometry Usage in Pharmaceutical Sector”

In China, market expansion is being driven by an increase in medical tourism, expanding research efforts, rising mass spectrometry usage in the pharmaceutical and food testing sectors, and rising consumer demand for high-quality healthcare.

Due to the existence of a strong research base for the creation of novel medications and the rise in popularity of innovative platforms across numerous fields, it is expected that the market in China would expand at the fastest rate.

How Will Demand for Q-TOF Mass Spectrometry Fare in Europe?

“Increasing Focus on Proteomics Analysis and Biomarker Discovery”

Research organizations in Europe are investing heavily in proteomic analysis and biomarker discovery to create novel treatments and medications. Q-TOF mass spectrometry plays a vital role in the aforementioned research interests as it allows the characterization of proteins and biomolecules.

Supportive government initiatives to promote medical R&D in countries such as Germany, France, Italy, and the United Kingdom are also forecasted to promulgate demand for Q-TOF mass spectrometry over the next ten years.

Category-wise Insights

Which Application Will Lead Revenue Generation for Market Players?

“High Need for Drug Component Analysis in Biotechnology Applications”

Based on application, the Q-TOF mass spectrometry market is divided into biotechnology, pharmaceuticals, food & beverage testing, environmental testing, petrochemicals, and others.

• Demand for Q-TOF mass spectrometry in biotechnology applications accounts for around 40% share of the global marketplace at present.

Surging demand for hyphenated and tandem techniques in biotechnology applications. Technological advancements in Q-TOF mass spectrometers, including fast speed, increased resolution, and higher accuracy are driving their demand in biotechnology applications.

From the initial stages of drug discovery to late-stage clinical trials and research, Q-TOF mass spectrometry is crucial to the biotechnology sector. Thus, it is projected that rising funding in the biotechnology sector will fuel market growth.

Rising need for drug component analysis & biomolecule analysis is driving the demand for Q-TOF mass spectrometry in biotechnology applications. The requirement for a cost-effective system for the analysis of samples and the rising demand for automation in diagnostic approaches are driving demand for Q-TOF mass spectrometry in the field of biotechnology. Manufacturers are encouraged to concentrate on the development of new products.

Additionally, innovations in Q-TOF mass spectrometry devices are anticipated to influence market trends. Complex biological mixtures are separated using cutting-edge methods such as capillary electrophoresis and ion mobility spectrometry.

Competitive Landscape

Leading Q-TOF mass spectrometer manufacturers are focusing on launching new products to boost their revenue generation capacity and improve market presence on a global scale.

• In June 2023, Thermo Fisher Scientific Inc., a leading name in the life sciences space, unveiled a new mass spectrometer with some of the most significant advancements that the technology has seen in the past 15 years. The company’s Orbitrap™ Astral™ mass spectrometer provides deep proteome coverage with fast throughput and high sensitivity.

Key Segments of Q-TOF Mass Spectrometry Industry Research

• By Type :

  • Below 2,000 FWHM
  • 2,000 to 5,000 FWHM
  • Above 5,000 FWHM

• By Application :

  • Biotechnology
  • Pharmaceuticals
  • Food & Beverage Testing
  • Environmental Testing
  • Petrochemicals
  • Others

• By Region :

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA